Unions blame ‘greed’ by healthcare providers, state officials say pricey weight-loss meds and increasing demand for care are ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN ...

The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and Zepbound — the brand name of tirzepatide, threatening a workaround that allowed ...

The first time around, 59-year-old James Brown lost a stone and a half when he took medication that aids weight loss. This ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

“Without meaningful intervention, current trends in enrollment, utilization, and health care cost inflation will continue ... at budget hearings that Wegovy, Ozempic and other popular diabetes ...

“Without meaningful intervention, current trends in enrollment, utilization, and health care cost inflation will continue ... at budget hearings that Wegovy, Ozempic and other popular diabetes ...

As weight-loss injectables like Ozempic skyrocket in popularity, a new offshoot trend is starting to take hold: microdosing.

Costly drugs: The drugs prescribed to fight obesity have been driving up the cost of Medi-Cal, the state program that ...

Mukhopadhyay took Mounjaro, an antidiabetic medication also used for weight loss, and saw dramatic results—losing 15 percent of her body weight over 18 months. She was feeling physically better, ...